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Reactiveoxygenspecies(ROS)arehighlyreactivemolecules,mainlygeneratedinsidemitochondriathatcanoxidizeDNA,proteins,
and lipids. At physiological levels, ROS function as “redox messengers” in intracellular signalling and regulation, whereas excess
ROSinducecelldeathbypromotingtheintrinsicapoptoticpathway.RecentworkhaspointedtoafurtherroleofROSinactivation
of autophagy and their importance in the regulation of aging. This review will focus on mitochondria as producers and targets
of ROS and will summarize diﬀerent proteins that modulate the redox state of the cell. Moreover, the involvement of ROS and
mitochondria in diﬀerent molecular pathways controlling lifespan will be reported, pointing out the role of ROS as a “balance of
power,” directing the cell towards life or death.
1.Introduction
Fromtheﬁrstobservationoftherealmitochondrialstructure
in 1950 [1], it was clear that this particular composition
reﬂected the diﬀerent functions of this organelle. Mito-
chondria are delimitated by double-membrane architecture,
an outer membrane of eukaryotic origin and an inner
membrane characterized by the absence of cholesterol and
the presence of cardiolipin, typical elements of bacterial
membranes. The inner membrane is organized in character-
istic folds, termed cristae, which protrude into the matrix
and accommodate the respiratory chain complexes. In
healthy cells, the inner membrane is impermeable to ions
[2], which allows the electrons transport chain (ETC) to
actively build up the proton gradient. The mitochondrial
membrane potential (ΔΨm) results from the diﬀerence in
electrical potential generated by the electrochemical gradient
across the inner membrane. Through oxidative phospho-
rylation, mitochondria play their essential role to supply
the cell with metabolic energy in the form of ATP. As a
consequence, they are also the primary source of cellular
reactive oxygen species (ROS), especially at level of the
respiratory chain complexes I and III, where electrons
derived from NADH and ubiquinone can directly react with
oxygen or other electron acceptors and generate free radicals
[3, 4]. Therefore, ROS are a normal side product of the
respiration process, and they react with lipids, protein, and
DNA, generating oxidative damage. Indeed, mitochondria
are the major site of ROS production, but also the major
targets of their detrimental eﬀects, representing the trigger
for several mitochondrial dysfunctions. In this review, we
will focus on this deadly liaison, with particular attention on
ROS production, mitochondrial ROS targets, and their role
in apoptosis, autophagy, and aging.
2. Mitochondrial ROS Production
Mitochondria are responsible for 90% of the energy that
cells, and thus tissues, organs, and the body as a whole need2 Journal of Signal Transduction
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Figure 1: Mitochondrial sources of ROS and mitochondrial ROS targets. ROS generators (red) and ROS targets (yellow) are shown in
their precise localizations inside mitochondria. Dotted yellow trace encloses the permeability transition pore components. See text, in
particular sections 2 and 3, for further details. Abbreviations: OMM: outer mitochondrial membrane; IMS: intermembrane space; IMM:
innermitochondrialmembrane;MAOA/B:monoamineoxidasesAandB;Cyt.b5reduct.:cytochromeb5reductase;DHOH:dihydroorotate
dehydrogenase; mGPDH: glycerol-3-phosphate dehydrogenase; I, II, III, and IV: Complex I to IV of the respiratory chain; Q: coenzyme Q;
Cyt. c: cytochrome c; KGDHC: α-ketoglutarate dehydrogenase complex; PGDH: pyruvate dehydrogenase complex; e−:e l e c t r o n s ;V D A C ,
voltage-dependentanionchannel,Cycl.D:cyclophilinD;ANT:adeninenucleotidetranslocase;Pol.Γ:polymeraseγ;mtDNA:mitochondrial
DNA.
to function. Hence, they are known as the “cells power-
house,” the core of cellular energy metabolism, being the
siteofmostATPgenerationthroughmitochondrialoxidative
phosphorylation (OXPHOS) [5].
In this process, electrons liberated from reducing sub-
strates are delivered to O2 establishing an electrochemical
gradient used to drive ATP synthesis. During the OXPHOS,
the reduction of oxygen by one electron at a time (O2 →
O2
−•→H2O2 →• OH → H2O) produces ROS, relatively
stable intermediates with one unpaired electron [6–8].
Although Brown and Borutaite in their recent review have
presented a number of examples supporting the point of
view that mitochondria are not a major source of ROS in
the cell [9], the fact that oxidative phosphorylation accounts
for 90% to 95% of cellular oxygen consumption and that
3% from that pool can be converted to superoxide is a
very strong argument in favour of mitochondria as a main
s o u r c eo ft h i so x y g e nr a d i c a l .H e n c e ,i ti saﬁ r mp a r a d i g m
that mitochondria are also the major source of ROS in
mammalian cells (Figure 1).
The primary ROS generated by mitochondria, as a result
of monoelectronic reduction of O2, is superoxide anion
(O2
−•) that is the precursor of most ROS and a mediator
in oxidative chain reactions. In vivo, O2
−• is produced
both enzymatically by NADPH oxidase, cytochrome P450-
dependent oxygenases, and xanthine oxidase and non-
enzymatically, when a single electron is directly transferred
to O2 [8]. In addition, O2
−• may react with other radicals
including nitric oxide (NO•) producing reactive nitrogen
species (RNS) [10]. Dismutation of O2
−•, either sponta-
neously [11], or through a reaction catalyzed by superox-
ide dismutases (SODs) [12], produces hydrogen peroxide
(H2O2)[ 13]. H2O2 generated in mitochondria has many
possible fates. Because H2O2 is relatively stable and mem-
brane permeable, it can diﬀuse within the cell and be
eliminatedbycytosolicormitochondrialantioxidantsystemsJournal of Signal Transduction 3
such as catalase, glutathione peroxidase, and thioredoxin
peroxidase [14]. Mitochondrially generated H2O2 can also
act as a signaling molecule in the cytosol, aﬀecting multiple
networksthatcontrol,forexample,cellcycle,stressresponse,
energy metabolism, and redox balance [15–17].
Whennotmetabolized,H2O2 canbefurthertransformed
to hydroxyl radical (•OH), in the presence of metal ions, by
Fenton reaction [18]. •OH is one of the strongest oxidants
in nature, is highly reactive, and generally acts essentially
as a damaging molecule. For this reason, mitochondria are
believed to have developed eﬃcient H2O2 removal systems,
as well as metal-chelating mechanisms, such as chaperone
proteins, preventing the formation of this radical.
At least, ten mammalian mitochondrial enzymes con-
tribute to ROS production [17, 19] even if their capacity
of ROS producing greatly diﬀer in a tissues-speciﬁc manner
[20]. In vitro experiments demonstrate that mitochondria
isolated from mouse heart, brain, and kidney have selective
substrate and inhibitor preferences for H2O2 generation and
that the apparent sites of H2O2 generation are both substrate
and organ speciﬁc [21].
The major bulk of mitochondrial ROS generation occurs
at the electron transport chain, as a byproduct of respiration
[7, 8, 22]. Cytochrome c, oxidase (Complex IV) is the
terminal component of the ETC, receives four electrons from
cytochrome c and reduces one O2 molecule to two H2O. It
retainsallpartiallyreducedintermediatesuntilfullreduction
is achieved and does not seem to release these intermediates
in measurable quantities [6].
Historically, the ﬁrst mitochondrial site producing ROS
was identiﬁed at the Complex III located at the inner side of
inner mitochondrial membrane (bc1 complex, ubiquinone:
cytochrome c reductase). The primary ROS produced at this
site is O2
−•, through the referred Q-cycle [23]. Despite the
recent advances in understanding the structure of the bc1
complex, a mechanism of O2
−• production is not yet known
[24–26].
Succinate dehydrogenase (Complex II, SDH) is a ﬂavo-
protein located at the inner surface of inner mitochondrial
membrane.Althoughoxidationofsuccinatecantheoretically
produce ROS with a high rate, signiﬁcant O2
−• formation
from this enzyme has not been measured so it is still
unclearwhetherSDHproducesROSinsitu,inmitochondria.
Despite the lack of ROS formation by Complex II itself, suc-
cinateisanimportantsourceofROSinmanytissuesthrough
a mechanism involving reverse electron transfer. This par-
ticular phenomenon may result from high mitochondrial
membrane potential, which thermodynamically favourites
electron donor from Complex II to I. Because of this, suc-
cinatemaypromoteROSgenerationatComplexIlevel[6,7].
Mitochondrial Complex I, “NADH dehydrogenase,” in
the inner face of inner membrane provides a major entry
point for electrons into respiratory chain. It is a signiﬁcant
source of ROS [27]i np a r t i c u l a rO 2
−• [28]a n dH 2O2
although whether or not Complex I is the major site of ROS
production in intact mitochondria in vivo is a complicated
issue. Indeed all the evidence on ROS production by
Complex I was obtained in vitro with isolated mitochondria
[29].
There are other mitochondrial nonrespiratory chain
enzymes that produce ROS although pinpointing their
speciﬁc contribution to total mitochondrial ROS production
remains unclear.
Mitochondrial cytochrome b5 reductase is located in the
outer mitochondrial membrane [30] .T h ee n z y m ei sw i d e l y
distributed in mammalian tissues and may be involved in
O2
−• generation with a very high rate ∼300nmoL per min
per mg protein [31].
Monoamine oxidases (MAO-A and MAO-B) are also
located in the outer mitochondrial membrane and ubiq-
uitously expressed in various mammalian tissues. These
enzymes catalyze the oxidation of biogenic amines accom-
panied by the release of H2O2 [32].
Dihydroorotate dehydrogenase (DHOH) is located at the
outer surface of inner mitochondrial membrane. It catalyzes
the conversion of dihydroorotate to the pyrimidine base,
orotate, which is a step in the de novo synthesis of uridine
monophosphate. The DHOH is ubiquitously distributed in
mammalian tissues, and it is considered a mitochondrial
sourceofO2
−•andH2O2 althoughthecapacityofDHOHto
produce O2
−• requires further clariﬁcation [33].
Mitochondrial dehydrogenase of α-glycerophosphate
(Glycerol-3-Phosphate Dehydrogenase, mGPDH) is located
at the outer surface of inner mitochondrial membrane. The
mGPDH is involved in lipid metabolism and in the so-called
glycerol phosphate shuttle capable of regenerating cytosolic
NAD+ from the NADH formed in glycolysis. It is ubiq-
uitously but unequally expressed in various mouse tissues
and mediate the production of H2O2 [34, 35].
Mitochondrial aconitase is an enzyme localized to the
matrix space of mitochondria; it participates in tricarboxylic
acid cycle catalyzing a conversion of citrate to isocitrate. The
enzyme contains an iron-sulfur cluster that can be oxidized
by O2
−• or H2O2 producing •OH [36].
Ketoglutarate dehydrogenase complex (KGDHC, 2-
oxoglutarate dehydrogenase) is an integral mitochondrial
enzyme tightly bound to the inner mitochondrial membrane
on the matrix side [37]. It catalyzes the oxidation of α-
ketoglutarate to succinyl-CoA in the tricarboxylic acid cycle.
Structurally, KGDHC is composed of three enzymes: α-
ketoglutarate dehydrogenase (E1 subunit), dihydrolipoam-
idesuccinyltransferase(E2subunit),andlipoamidedehydro-
genase (E3 subunit). The E3 component appears to be the
principal ROS source generating O2
−• and H2O2 [38, 39].
Pyruvate dehydrogenase complex (PGDH) localized into
mitochondrial matrix contains ﬂavoenzyme dihydrolipoyl
dehydrogenase subunits like KGDHC, which are very impor-
tant ROS sources [38].
3. Mitochondrial Targets of ROS
A wide range of mitochondrial ROS-induced damages
has been described, including protein carbonylation, lipid
peroxidation, or mtDNA damage. These damages, either
individually or collectively can lead to a cellular energetic
catastrophe. In this section, we are going to treat the most4 Journal of Signal Transduction
important mitochondrial targets of ROS action, also sum-
marized, with their mitochondrial localization, in Figure 1.
3.1. Oxidative Damage of mtDNA. The sequence and orga-
nization of the human mitochondrial genome has been
presentedfortheﬁrsttimebyAndersonetal.inthelandmark
paper in 1981 [40]. Mitochondrial DNA (mtDNA) was iden-
tiﬁed as a 16.5 kb circular molecule encoding 13 polypep-
tides, 22 tRNAs, and 2 rRNAs. All of the above mentioned
are components of mitochondrial respiratory machinery.
MtDNAisattachedtotheIMMonthematrixside,rendering
it particularly prone to oxidative damage, as the aforesaid
localization is in immediate proximity to the cells’ major
source of ROS, that is to the mitochondrial respiratory
chain. ROS accumulating within the matrix are in such a
case explicitly deleterious. Additionally, the lack of introns,
histones, and other DNA-protecting proteins as well as DNA
repair systems inferior to those observed in nDNA allows
increased deterioration [41, 42]. However, mitochondria
possess a number of DNA repair enzymes such as MYH (2-
OH-A/adenine DNA glycosylase) and OGG1 (8-oxoG DNA
glycosylase) [43] .I nn u c l e i ca c i d s ,b o t ht h eb a s e sa sw e l la s
the sugar are prone to ROS attacks. This may lead to modiﬁ-
cations of base and abasic sites and result in strand breaks
[44]. A good example that may be the addition of the
hydroxyl radical to the double bonds may occur. In this case
thereactionrate-limiting factorisdiﬀusion of approximately
4.5 × 109 to 9 × 109 M−1s−1 [45]. The main outcome of
the above-mentioned attacks is the hydroxylation of pyrim-
idines at C5 and C6 as well as purines at C4, C5, and C8.
So far over 80 diﬀerent oxidized bases in DNA exposed to
oxidant factors, such as H2O2 and singlet oxygen, have been
identiﬁed [45, 46]. Experiments from the mid 1980s led
to the establishment of a dependable marker of these
alterations—8-hydroxy-deoxyguanosine (8-OHDG) [47–
51]. An increase in 8-OHDG is a sign of mtDNA fragmenta-
tion and is observed in events involving oxidative stress [52].
Alterations in the mitochondrial genome are reﬂected
in a number of disorders, most of which involve impaired
respiration and oxidative phosphorylation. As a matter of
fact, over 150 pathogenic mutations have been identiﬁed in
the mtDNA, which cause human diseases [53]. The scope of
these disorders has been positively correlated with increasing
age and tissues with high-energy demands [54–58]. Individ-
uals may develop a number of symptoms including ataxia,
dystonia, epilepsy, dementia, peripheral neuropathy, optic
atrophy, and deafness [59]. A number of authors report
associations between mtDNA point mutations and neurode-
generative diseases [60–63]. However, some of the mutations
are yet to be conﬁrmed and therefore are under dispute.
On the other hand, in some cases, such as Parkinson’s
disease (PD), there seems to be a consistent PD-associated
haplogroup [64–66]. Brains of aged individuals as well
as those with neurodegenerative diseases exhibit increased
levels of mutated mtDNA, particularly in substantia nigra
neurons, as compared to hippocampal neurons [67]. It is
not clear, whether these mutations are an eﬀect of oxidative
stress. Nevertheless, such explanation seems reasonable.
3.2. Oxidative Damage of Mitochondrial Proteins. Oxidative
modiﬁcation of proteins (oxidation of arginine, lysine,
threonine, and proline residues) induces the formation
of protein carbonyls, commonly detected under oxidative
conditions, in aged cells and in aged animal tissues. On
the other hand, peroxynitrite oxidizes tryptophan, cysteine,
and tyrosine protein residues as well as unsaturated fatty
acidsandlowmolecularmasscomponentsoftheantioxidant
defense system like glutathione, α-tocopherol, and ascorbate.
Additionally, oxidative damage can aﬀect carbohydrates,
which, when oxidized, may be used in glycation process
causing the formation of glycation end products. It has
been repeatedly shown that the accumulation rate of such
oxidatively modiﬁed proteins (under oxidative stress or in
aging) is tissue speciﬁc and depends on protein type [68].
3.2.1. Mitochondrial Respiratory Chain. The mitochondrial
respiratory chain, due to its natural imperfections, can be
considered a peculiar superoxide generator. In such a case,
complexes of the respiratory chain are in the ﬁrsthand
expositiontooxidativemodiﬁcationbecausetheyarepresent
atthesitesofROSproduction.Thehighsensitivityoftheres-
piratory chain complexes to oxidizing agents results from the
fact that they contain iron-sulfur clusters (Complexes I, II,
andIII),hemegroups(ComplexesII,III,andIV)andcopper
centers in complex IV, all of which can be a site of direct
ROS attack, and their oxidative modiﬁcations can manifest
with a decrease of their enzymatic activity and dysfunction
of the whole respiratory chain [69–71]. Interestingly, three
mechanisms have been reported in the NO• inhibition of
Complex I: S-nitrosation, tyrosine nitration and damage to
FeS centres [72]. The inhibition of mitochondrial Complex
I activity is consistently detected in Parkinson’s disease pa-
tientsaswellasinmitochondrialtoxinmodelsofthedisorder
[73].
C y t o c h r o m ec( ac o m p o n e n to fO X P H O S )c a nb em o d -
iﬁed by nitration of its tyrosine residues, which also aﬀects
electron ﬂow through the respiratory chain [74]. Nitration
of a single tyrosine residue in cytochrome c by a relatively
low dose of peroxynitrite resulted in the upregulation of its
peroxidase activity for H2O2 and in the impairment of the
membrane potential formation [75]. Oxidative damage of
individual respiratory chain complexes results not only in a
decreased eﬃciency of ATP production but can also increase
ROS production by oxidatively aﬀected OXPHOS subunits,
contributing in this way to the intensiﬁcation of oxidative
stress.
3.2.2. Mitochondrial Carriers. The eﬀect of oxidative stress
(i.e., caused by site-speciﬁc metal-catalyzed oxidation) on
mitochondrial carriers was studied intensively in a model
exploiting components of the mitochondrial permeability
pore: the adenine nucleotide translocase (ANT), porin
(VDAC), and creatine kinase. ANT contains many pro-
line, arginine, and lysine residues, which are very sensible
for such type oxidation (systems: vanadyl/H2O2-generating
hydroxyl free radicals or Cu2+/tert-butyl hydroperoxide).Journal of Signal Transduction 5
Moreover, ANT is localized in the IMM in cardiolipin-
rich (containing unsaturated fatty acids) domains. This can
explain its sensibility to oxidation also by lipid peroxidation
products. In 1998, interesting studies of Sohal’s group
revealed that ANT in mitochondria of ﬂight muscles is sig-
niﬁcantly carbonylated in senescent ﬂies. Surprisingly, ANT
was the only mitochondrial protein demonstrating age-
related increase of carbonylation in this experimental model.
Invitroexperimentsbasingontheexposureofisolatedmito-
chondria to the hydroxyl free radicals showed an increased
level of carbonylated ANT exhibiting lower nucleotide
exchange activity [76].
In addition to controlling the release of superoxide from
mitochondria [77], VDAC, which accounts for about 10% of
outer mitochondrial membrane (OMM) proteins, can also
be a target for intracellular O2
−•. Madesh and Hajnoczky
observed that VDAC-dependent permeabilization of the
OMM and cytochrome c release can be caused by superoxide
butnotbyH2O2.Moreover,theobservedeﬀectofsuperoxide
does not require the contribution of the proapoptotic
proteins like Bak or Bax [78]. On the other hand, another
component of the mitochondrial permeability transition
pore (mPTP), mitochondrial creatine kinase, present in the
intermembrane space (IMS) is aﬀected by H2O2 and perox-
ynitrite. The drop in the creatine kinase activity is caused
by oxidative modiﬁcations of its sulfhydryl groups and
aromatic aminoacids [79, 80].
3.2.3. Permeability Transition Pore as a Ros Target. Based on
the literature, permeability transition pore (mPTP) seems to
be a multiprotein complex with variable composition. The
main core of mPTP consists of the voltage-dependent anion
channel (VDAC), ANT, and cyclophilin D localized in the
outer-, inner mitochondrial membrane, and mitochondrial
matrix, respectively [81–83]. Still there is no consensus
concerning exact composition of mPTP. Recent studies with
the use of transgenic VDAC1 or ANT1 knockout mice seem
to contradict the stereotype model of PTP. To ﬁnd more
about the presence of VDAC, ANT, or cyclophilin D in
the mPTP, refer to [84–86]. The other components, such
as hexokinase, benzodiazepine receptor, and creatine kinase
seem to play a regulatory role rather than being structural
components of the mPTP. However, regardless of the
composition of mPTP, it has been repeatedly described
already in 90ties that oxidation of critical thiol residues of
ANT induces opening of the mPTP and collapse of mito-
chondrial membrane potential, mitochondrial swelling, and
cytochrome c release. When the thiol groups of ANT are in
reduced state, probability of mPTP opening is much lower
than when they are oxidised and cross-linkage of ANT thiol
groups can occur. Especially oxidation of the Cys160 and
Cys257 of ANT promotes PTP opening [87]. Moreover, Cys56
oxidation alters the conformation of ANT inducing it to
becomeanonspeciﬁcpore,thusmimickingtheeﬀectofCa2+
which converts ANT into a large channel [88]. Sensitivity of
ANT to the oxidizing agents makes mPTP one of the direct
sites of ROS action in mitochondria.
3.2.4. Aconitase. In Section 2,w eh a v ea r g u e dm - a c o n i t a s ea s
a source of ROS, but, at the same time, it can be considered
a well-established example of oxidative damage targeting a
mitochondrial enzyme. In fact, its susceptibility to oxidative
damage mainly from superoxide is related to the iron-sulfur
cluster present in the active site of the enzyme [89].
3.2.5. Polymerase γ. Nearly 10 years ago, the studies of
Copeland’s group conﬁrmed that polymerase γ present in
themitochondrialmatrixresponsibleformtDNAreplication
can also be considered as an intrinsic target for ROS. The
group found that the catalytic subunit of polymerase γ is
one of the proteins most abundantly oxidized in the mito-
chondrial matrix and correlated oxidative modiﬁcation of
polymerase γ with the drop of its enzymatic activity. This
in turn can result in the reduction of mtDNA repair and
replication [90].
3.3. Peroxidation of Mitochondrial Lipids. In mitochondrial
membranes, unsaturated fatty acids, being components of
phospholipids, are very susceptible to oxidation by the
hydroxyl radical. Lipid peroxidation products, lipid hydrop-
eroxides, generate very reactive unsaturated aldehydes like
4-hydroxy 2-nonenal (4-HNE), malondialdehyde (MDA),
and acrolein. Moreover, the generation of lipid radicals can
induce a chain reaction leading to the generation of new
radicals which intensiﬁes lipid peroxidation. Lipid peroxides
cause various eﬀects in the cell. It has been reported that
oxidatively modiﬁed lipids aﬀect membrane ﬂuidity; this is
the case of lipid peroxidation at inner mitochondrial mem-
brane level, leading to increased permeability to protons and
uncoupling of oxidative phosphorylation [91]. Moreover,
lipid radicals diﬀuse easily in the membranes and can
covalently modify membrane proteins [92], as well as cause
“lipoxidative” damage to the mtDNA. For example, 4-HNE
inhibits ANT activity in isolated mitochondria due to the
modiﬁcation of critical sulfhydryl groups in ANT [93]. It has
also been suggested that the protein carbonylation process
is more often related to the lipid-protein oxidation than the
direct protein oxidation by reactive oxygen species [94, 95].
4. Mitochondrial ROS Measurements
Direct imaging of ROS in biological samples has proven to
be extremely challenging. A large amount of methods for
ROS monitoring has been developed in the last years, includ-
ingﬂuorimetric,spectrophotometric,andchemiluminescent
assays [96].
Among diﬀerent ﬂuorescent assays, MitoSOX is largely
used to visualize superoxide ions inside mitochondria [97].
This reagent is a cell permeant dye that once in mito-
chondria is oxidized by superoxide and trapped inside
organelle, becoming weakly ﬂuorescent. Subsequent binding
with nucleic acid permit to the dye to show high ﬂuores-
cence, with excitation at 510nm and emission at 580nm.
It can be considered a superoxide-speciﬁc probe, because
its reactivity for hydrogen peroxide or reactive nitrogen6 Journal of Signal Transduction
species is relatively low. However, several caveats exist
in using MitoSOX probe [98, 99]; one of the mostly frequent
is, without doubts, the photochemical oxidation of the dye,
anaspectwhichhastobetakenintoconsiderationforproper
interpretation of results.
One of the widespread methods to detect H2O2 produc-
tion by mitochondria is based on 2 ,7  dichloroﬂuorescein
(DCF-H2) oxidation. This dye is commercialized as a diac-
etate chemical probe, in order to be cell permeant, and, once
deacetylated from cellular diesterases, it becomes imperme-
able and weakly ﬂuorescent. DCF-H2, when oxidized by
H2O2, is converted into 2 ,7 -dichloroﬂuorescein (DCF),
a high ﬂuorescent component (λex 500nm −λem 520nm)
[100]. DCF formation is directly proportional to H2O2
production; therefore, for data analysis is preferable to
calculate variation in ﬂuorophore accumulation speed. One
of the most relevant limitations of DCF is that it cannot
be used to measure H2O2 production exclusively inside
mitochondria. Mitochondria peroxy yellow 1 (MitoPY1), a
new type of ﬂuorophore for imaging mitochondrial H2O2
in living cells with ROS and spatial speciﬁcity [101], may
representtheanswertothisproblem,butfurtherstudieshave
to be performed to clarify its real eﬃcacy.
Recently, a new highly speciﬁc ﬂuorescent probe has
been introduced in methods for ROS measurements. HyPer
(distribuited by Evrogen) is a genetically encoded ﬂuores-
cent sensor speciﬁc for H2O2 and consists in a circularly
permuted yellow ﬂuorescent protein (cpYFP), inserted into
the regulatory domain of OxyR, a hydrogen peroxide-
sensitive transcription factor isolated from E. coli.H y P e ri sa
ratiometric indicator; the excitation wavelength in normal
condition is 420nm, and, in the presence of H2O2,ar e d -
shiftmovingexcitationto500nmoccurs.Emissionspectrum
has a maximum at 516nm, independently from oxidants
activity. The most palatable feature is the possibility to
direct HyPer to mitochondrial matrix using COX-targeting
sequence, permitting directing fast measurements of mito-
chondrial ROS production [102]. HyPer is not the ﬁrst
ratiometric probe used for ROS assessment. In 2004,
Tsien and coworkers developed ratiometric redox-sensitive
versions of GFP, termed redox-sensitive green ﬂuorescent
proteins (roGFPs) [103, 104]. When a population of roGFP
is oxidized, excitation increases at the 400nm peak while
diminishing at the 480nm peak; the emission is measured
at 510nm. Because the indicator is genetically encoded, it
can be targeted to speciﬁc proteins or organelles of interest
and expressed in a wide variety of cells and organisms (for
an exhaustive discussion of the biophysical properties and
development of these probes, see [105]).
Fluorescent dyes show the high advantage to be easy to
use, fast, and weakly invasive, leading to a quite accurate
calibrationusingperoxide(ornitricoxide)donors.However,
they are fast degradable and easily produce artefacts; in fact,
as cited above, high light intensity could induce the activa-
tion of the dye, with consequent artefactual ROS generation,
resulting in nonspeciﬁc signal ampliﬁcation.
5.DeadlyLiaisons:ROSandMitochondriain
the Control of Cell Death
As mentioned in the introduction, mitochondria are often
targets of high ROS exposure with deleterious consequences,
such as oxidative damage to mitochondrial DNA. This is
certainly true, but recent evidence has suggested a deep in-
volvement of ROS also in the extrinsic pathway of apoptosis.
The extrinsic receptor-mediated death pathway requires
eﬀective engagement between the death receptors found on
thesurfaceofthecellmembranesandtheirrespectiveligands
[106]. The receptor-mediated pathway involves death recep-
tors from the tumor necrosis factor (TNF) superfamily such
as TNF, CD95 (Fas), and TNF-related apoptosis-inducing
ligand (TRAIL) receptors. Fas and TNFR1 activation is
knowntogenerateROSinresponsetostimulation,whichhas
been hypothesized to be due to the production of superoxide
(O2
•−) because of the formation of lipid raft-derived
NADPH oxidase platforms. This lipid raft-associated ROS
downstream generation may be of high importance in
inductionofapoptosisornecrosis[107,108].Moreover,ROS
are required for apoptosis induction by Fas ligand (FasL) in
primary lung epithelial cells. ROS mediate the downregula-
tion of FLIP (FLICE inhibitory protein, a strong inhibitor
of apoptosis) by ubiquitination and subsequent degradation
by proteasome or through nitric oxide (NO) scavenging that
prevents FLIP S-nitrosation and cytoprotection [109].
Other evidences underline how ROS generation may
inﬂuence the intracellular milieu, favouring the eﬀective exe-
cution of the downstream events leading to extrinsic apopto-
sis. ROS has been shown to sensitize cancer cells to TRAIL-
induced apoptosis [110], and massive upregulation of CD95
and TRAIL death receptors have also been observed in
response to hydrogen peroxide, through a mechanism
involving the activation of NF-kappaB [111]. Interestingly,
theabilityofH2O2 topromoteapoptosis,throughtheactiva-
tionofJNK,seemsinhibitedinlungﬁbroblastsfromTNFR1-
deﬁcient mice [112]. ROS activation of JNK can induce
extrinsic or intrinsic apoptotic signaling. TNFα is a potent
activator of the MAPK cascade, and TNFα-induced ROS
cause oxidation and inhibition of JNK-inactivating phos-
phatases, by converting their catalytic cysteine to sulfenic
acid, with a consequent prolonged JNK activation, which is
required for cytochrome c release and caspase 3 cleavage, as
well as necrotic cell death [113].
Upstream of JNK is the redox-sensitive MAPK kinase
kinase, ASK1. Under non-oxidizing conditions, reduced
thioredoxin1 (Trx1) binds ASK1; the resultant Trx1/ASK1
complex, called “ASK1 signalosome,” functions as a perfect
redox switch. Robust and sustained cellular ROS induce
the dissociation of oxidized Trx1 from the complex and let
to complete the activation of ASK1, also through the
recruitment of TRAF2/6 [114]. Moreover, ASK2, another
member of the ASK family, binds and stabilizes ASK1 not
only in the cytosol, but also in nucleus and mitochondria.
Recently, Saxena et al. have shown how the thioredoxin-
interacting protein TXNIP, a ubiquitously expressed redox
protein that promotes apoptosis, could shuttle from nucleus
to mitochondria under oxidative stress, forming a complexJournal of Signal Transduction 7
with mitochondrial Trx2 and removing it from ASK1. This
alleviation of Trx2-mediated inhibition results in phospho-
rylation of ASK1 and consequent induction of the mito-
chondrial pathway of apoptosis, with cytochrome c release
and caspase-3 cleavage [115].
The major ROS target inside mitochondria is undoubt-
edly the permeability transition pore (see Section 3). Oxida-
tive modiﬁcations of mPTP proteins will signiﬁcantly impact
mitochondrial anion ﬂuxes [116]. In response to proapop-
totic stimuli, including ROS and Ca2+ overload, the mPTP
assumesahigh-conductancestatethatallowsthederegulated
entry of small solutes into the mitochondrial matrix along
their electrochemical gradient. This phenomenon, which
is known as mitochondrial permeability transition (MPT),
results in immediate dissipation of the mitochondrial mem-
brane potential and osmotic swelling of the mitochondrial
matrix [2]. Mitochondrial swelling is deﬁned as an “increase
in the volume of mitochondria due to an inﬂux of ﬂuid.”
The mechanism concerns an early phase of mitochondrial
swelling, which involves movement of water from the inter-
cristal spaces into the matrix; when this water movement
continues, the pressure applied to the outer membrane from
the increased matrix volume leads to the opening of mPTP
and/orruptureofthemitochondrialoutermembrane,allow-
ing further matrix expansion [117]. This leads to the release
of cytochrome c and the subsequent engagement of the
Apaf-1-pro-caspase 9 apoptosome complex, which activates
downstream eﬀector caspases. Cytochrome c is present as
loosely and tightly bound pools attached to the inner mem-
brane by its association with cardiolipin; this interaction
must ﬁrst be disrupted to generate a soluble pool of this
protein. In 2002, the group of Orrenius elegantly showed
how oxidative modiﬁcation of mitochondrial lipids, specif-
ically cardiolipin, is fundamental for tightly bound pool of
cytochrome c mobilization, that is so detached because of
disturbances in membrane structure [118]. The cardiolipin-
boundcytochromecassumestheroleofamembrane-bound
peroxidase that can eﬀectively catalyze oxidative stress and
cause oxidation of cardiolipin if a source of oxidizing
equivalents, such as H2O2,i sa c t i v a t e d .T h i sc a nl e a dt o
a putative “oxidative wave propagation:” membrane-bound
cytochrome c may be seen as a mitochondrial death receptor
transducing proapoptotic signals into executing oxidative
cascades, with a consequent overload of oxidized cardiolipin
species, detachment of cytochrome c from the membrane
and formation of mPTP (reviewed in [119]). In this regard,
it has been recently shown that overexpression of human
telomerase reverse transcriptase (hTERT), the catalytic sub-
unit of the telomerase holoenzyme, alleviates cellular ROS
levels also through its mitochondrial localization, improving
activity of cytochrome c oxidase, blocking cytochrome c
release, mitochondrial membrane permeabilization, and
inhibiting apoptosis in cancer cells [120].
Thepathophysiologicalimportanceofintracellularredox
balance and apoptosis regulation was also taken in to
consideration during the study of cerebral cavernous malfor-
mations (CCMs) [121]. Ablation of Krit1, a protein whose
loss of function has been associated to this particular
pathogenesis, leads to a signiﬁcant increase in intracellular
ROS levels, due to the modulation of the expression of the
antioxidant protein SOD2 and to a drastic decrease of mito-
chondrial energy metabolism, with consequent increased
susceptibility to oxidative damage [121]. In the same
way, MUC1, an oncoprotein aberrantly expressed in acute
myeloid leukemia (AML) cells, regulates ROS levels and the
diﬀerentiation of hematopoietic cells [122]. MUC1 expres-
sionisassociatedwithattenuationofendogenousandH2O2-
induced intracellular levels of reactive oxygen species [123],
and, inhibition of MUC1 results in the disruption of redox
balance and thereby AML cell death [122].
RedoxregulationofproteinsbymoderatelevelsofROSis
observedinvarioussignalingpathways,includingautophagy,
a catabolic pathway for degradation of intracellular proteins
andorganellesviathelysosome[124].Autophagyisactivated
mainly by nutrient starvation, and it plays a dual role; it is
primarily a surviving mechanism, but it also leads to cell
death (called type III cell death) thus possibly acting as an
alternative to apoptosis. It is generally accepted that ROS
induce autophagy [125, 126], and that autophagy, in turn,
serves to reduce oxidative damage [124]. Given that, antiox-
idants may represent natural inhibitors of this process. As
a matter of fact, the p53-target gene TIGAR contributes
to the regulation of intracellular ROS levels by modulation
of the glycolytic pathway, increasing NADPH production
(with a consequent decrease in intracellular ROS levels) and
lowering the sensitivity of cells to p53-dependent apoptosis
induced by oxidative stress [127]. In this manner, TIGAR
inhibits autophagy induced by nutrient starvation and
metabolic stress, in a p53-indipendent way [128]. Moreover,
a mutant form of SOD1 (SOD1G93A, associated with one-
ﬁfthoffamilialamyotrophiclateralsclerosiscases[129])pro-
motes ROS accumulation and autophagy [130, 131], despite
its role in muscular atrophy induction has not been fully
understood. In transgenic mice spinal cord, SOD1G93A inter-
acts with p62, an LC3-binding partner known to target pro-
tein aggregates for autophagic degradation, suggesting that
p62 may direct mutant SOD1 aggregates to autophagy [132].
Because mitochondria are, at the same time, primary
source and target of ROS, they play a fundamental role
in ROS-mediated autophagy regulation. Indeed, cells use a
specialized form of autophagy, called mitophagy, to selec-
tively eliminate defective mitochondria. The term, coined by
Lemasters in 2007 [133], indicates a selective degradating
process to maintain a healthy population of mitochondria.
Increases in cellular ROS lead to loss of mitochondrial
membrane potential (ΔΨm), which is considered a trigger
for mitophagy [133]. Under serum deprivation, a typical
decrease in mitochondrial membrane potential is observed
in hepatocytes prior to engulfment by autophagosomes,
whereas Cyclosporin A (CsA), a mPTP inhibitor, prevented
this depolarization and the autophagosomal proliferation
[134, 135]. However, in diﬀerent setups represented by rat
pituitary GH3 cells [136] and muscles [137], Cyclosporin
A works as a strong autophagy-inducer: in particular, CsA
treatment in skeletal muscles of collagen VI knockout mice
(Col6a1 −/−), characterized by impaired autophagy, pres-
ence of abnormal mitochondria, and myoﬁber degeneration,
promotes autophagy with a concomitant block of apoptotic8 Journal of Signal Transduction
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Figure 2: ROS levels control cell fate. Low production of ROS works as trigger of autophagic/mitophagic process, with consequent removal
of damaged mitochondria and in turn cellular survival (upper panel). On the other hand, high levels of ROS lead to cell death promoting
the apoptotic pathway when prosurvival attempt fails (lower panel).
d e g e n e r a t i o na n dr e c o v e r yo fm u s c l es t r e n g t h[ 137]. This
discrepancy suggests that mitochondrial depolarization is
not general, leading event to rage the mitophagic process.
Abnormalities in mitochondrial respiration and in-
creased oxidative stress are observed in cells and tissues from
parkinsonian patients [138], which also exhibit increased
mitochondrial autophagy [139]. Two genes, which encode
the OMM kinase PINK1 and the E3 ubiquitin ligase parkin,
aremutatedinautosomalrecessiveParkinson’sdisease[140].
Parkin is able to induce mitophagy through translocation
from cytosol to mitochondria in many diﬀerent cellular
settings, after stress induction by mitochondrial uncouplers,
whichmimicdamagebydecreasingthemitochondrial mem-
brane potential [141], or by the administration of oxidative
stress inducers, such as Paraquat [142]. Moreover, Parkin
may signal the selective removal of defective mitochondria
within the cell. Overexpression of Parkin can eliminate
mitochondria with deleterious COXI mutations in hetero-
plasmic cybrid cells, thereby enriching cells for wildtype
mtDNA and restoring cytochrome c oxidase activity [143].
PINK1 (PTEN-induced kinase 1) mediates recruitment of
parkin to the damaged mitochondria and activates parkin’s
ligase activity [144], thereby promoting autophagy. Recently,
it has been shown that knockdown of PINK1 expression
also leads to mitophagy in SH-SY 5Y cells, due to mito-
chondrialfragmentationandmitochondrialROSproduction
[145]. PINK1 knockdown led to decreased transmembrane
potential, which was ameliorated by antioxidant MnTBAP
treatment, suggesting that ROS production is upstream of
mitochondrial depolarization [146].
Based on these observations, ROS act as signaling
molecules inﬂuencing cell fate. Undoubtedly, redox regula-
tion can promote both survival, during starvation for exam-
ple, as well as cell death, during oxidative stress. ROS play
the role of trigger in the early phase of autophagic process,
inducing cytoprotection by eliminating potential sources of
proapoptotic stimuli. On the other hand, if the prosurvival
attempt fails, ROS cause cell death which involves either the
autophagic or the apoptotic pathway, or both (Figure 2).
6. ROS as Key Regulators of Aging
The decline associated with aging is caused by the accumu-
lation of ROS, as supported by cellular and biological data
from diﬀerent model systems and organisms [147]. Indeed
defects in antioxidant defense mechanisms fail to protect
against oxidative damage, reducing lifespan [148, 149]a n d
causing cardiomyophaty, neurodegeneration [150], and can-
cer [151].
The relationship between mitochondria dysfunctions
observed during aging and ROS production is still debated.
However, it is clear that the decline of the integrity of mito-
chondria as a function of age is implicated in aging and age-
related diseases [147].
Given this wide scientiﬁc evidence, many studies were
aimed to identify the molecular mechanisms responsible for
ROS deleterious eﬀects on the aging process. Genes that
extend lifespan partially included those involved in oxidative
stress response, while partially were clustered in the IGF-
1/insulin-like signaling pathway [152, 153].Journal of Signal Transduction 9
A key mitochondrial eﬀector is the adapter protein
p66shc, which directly mediate, the production of ROS
within the mitochondria [154], participating in intracellular
pathwaysthatcontroloxidativestress,apoptosis,andlifespan
determination [155, 156]. Accordingly, p66shc knockout
mice are one of the best characterized genetic model of
longevity, is being more resistant to oxidative stress [157]
and protected against age-dependent, ROS-mediated cardio-
vascular complications induced by diabetes [158–160]. On
the contrary, overexpression of p66shc causes alterations of
mitochondrial Ca2+ responses (which is an early event of
mitochondrial damage) and fragmentation of mitochondrial
network[161],leadingtocytochromecreleaseandapoptosis
[162]. Orsini and coworkers showed, for the ﬁrst time,
that oxidative stress promotes a translocation of part of the
cytosolic pool of p66Shc to mitochondria, binding mtHsp70
in mitochondrial matrix [163]. The same group in 2005
claimed that p66Shc is rather present in the intermembrane
space, where it interacts with cytochrome c. This interaction,
whichresultsinH2O2 production[162],canbesupportedby
an earlier report showing that p66Shc has internally located
mitochondrial targeting sequence [164] .I no r d e rt oe x p l a i n
its activity, p66Shc has to be phosphorylated at serine 36 by
PKCβ,andthiseventleadstoaconsequentrecognitionbythe
prolyl isomerase Pin1, allowing p66Shc entrance into mito-
chondria[156].Ourrecentdatahaveindicatedthatp66Shcis
also present in MAM (mitochondria-associate membranes)
fraction, which consists in membranes interacting with
mitochondria [165, 166]. Interestingly, the level of p66Shc
in MAM fraction changes in an age-dependent manner
(MAM fraction isolated from livers of old animals contained
more p66Shc than MAM isolated from young individuals)
[167]. In response to the oxidative stress, high p66Shc Ser36-
phosphorylation status promotes both an additional intra-
cellular ROS generation and reduction of the antioxidant
defence system eﬃciency. The disturbance of the antioxidant
enzymeslevelisconnectedwiththerecruitmentofAkttothe
p66Shc-FOXO3a complex, resulting in a direct inactivation
of FOXO transcription factors by their phosphorylation
[168, 169]. In this way, genes encoding antioxidant enzymes
controlledbyFOXOtranscriptionfactorsaredownregulated,
with consequent increased ROS production and oxidative
stress. Accordingly, decrease of phosphorylated p66Shc is
accompanied by positive modulation of the antioxidant
defence system [170].
Many alterations that extend lifespan aﬀect not only
stress response proteins, such as p66shc, but also nutrient
sensors, such as insulin growth factor (IGF-1), target of
rapamycin (TOR) protein kinase, AMP kinase (AMPK),
sirtuins, and PGC-1α [171]. Caloric restriction (CR) is
the best example of signals that modulate the activity of
nutrients sensors, and it is the most robust intervention to
extend lifespan and ameliorate various diseases in mammals,
reducing oxidative stress and damage [172, 173]. Despite CR
was historically considered a nongenetic process regulating
lifespan, many recent lines of evidence have suggested its role
in several signaling pathways, causing ROS reduction and
mitochondrial biogenesis [174].
Nutrient sensor IGF-1 signaling pathway was the ﬁrst
to be associated to CR-mediated regulation of lifespan in
animals. Indeed, heterozygous knockout mice for the IGF-
1r e c e p t o r( I g f r+ / −) live longer, show a delay in the onset of
pathologies, and display greater resistance to oxidative stress
[175, 176], suggesting that the eﬀects of the IGF-1 pathway
on longevity are closely related to mitochondrial protection
from oxidative damage. Accordingly in C. elegans, mutations
of downstream components of this pathway, such as age-1
(the homologue of PI3K) and akt-1 and akt-2 (the homo-
logue of AKT1 and AKT2), result in extension of lifespan
[153].
The most important targets regulated by IGF-1-signaling
pathway are the transcription factors FoxO [177]a n dT O R
protein kinase [178]. FoxO is required for the antiaging
eﬀects of the IGF-1 pathway [179, 180], once downregulated
by CR, since it induces the expression of several antioxidative
enzymes [181, 182], mediating the production of secondary
signals that regulates lifespan.
TOR is highly conserved during evolution and functions
as the major amino acid and nutrient sensor in the cell [183].
Much evidence points out the central role of this kinase in
lifespanextensionbyCR.Inyeast,C.elegans,andDrosophila,
T O Ri sr e q u i r e df o rt h ee ﬀects of dietary restriction, and,
importantly, its downregulation extends lifespan of all these
models [184] and in mice too [185].
Recently, other signaling proteins have been shown to
converge and regulate the FoxO transcription factors and
thus oxidative stress and aging. Speciﬁcally, the proteins
known as sirtuins, NAD-dependent histone deacetylases
[186], are activated during CR, when the NAD/NADH ratio
is elevated [187]. This group of proteins increases lifespan
in yeast, C. elegans,a n dDrosophila, and it is thought to act
similarly in mammals [188]. In this respect, aging is often
associated with reduced sirtuins levels. Sirtuins are mainly
antiaginggenesviathepromotionofmitochondrialfunction
and autophagy and inhibition of apoptosis. They also have
an inhibitory activity on ROS. Sirtuin function may be
enhanced by restricting caloric intake or increasing physical
activity, thereby, extending lifespan. Importantly, three of
seven mammalian sirtuins (SIRT3, 4, and 5) are targeted
to mitochondria, and SIRT1 is a regulator of mitochondrial
biogenesis [189]. SIRT3 is required for the maintenance of
mitochondrial integrity and metabolism during stress [190].
T h ep r o t e c t i v ee ﬀects of CR on oxidative stress and damage
are diminished in mice lacking SIRT3. SIRT3 reduces cellular
ROS levels dependent on SOD2. SIRT3 deacetylates two
critical lysine residues on SOD2 (Lys53/89) and promotes its
antioxidative activity. Importantly, the ability of SOD2 to
reduce cellular ROS and promote oxidative stress resistance
is greatly enhanced by SIRT3 [191]. In a very recent paper,
Chenetal.havereportedthatSOD2isalsoacetylatedatLys68
and that this acetylation decreases its activity. SIRT3 binds
to, deacetylates, and activates SOD2. Increase of ROS levels
stimulates SIRT3 transcription, leading to SOD2 deacetyla-
tion and activation [192].
Other studies conﬁrmed thatSIRT1is part of the insulin/
IGF-1 pathway, being able to deacetylate and, thus, activate
FoxO transcription factors [193]. Moreover, SIRT1 can10 Journal of Signal Transduction
activatePGC-1α(peroxisome-proliferator-activatedreceptor
γ coactivator-1α). Several data linked PGC-1α and aging.
First, PGC-1α is progressively downregulated during aging,
and this event is prevented by CR [194]. Furthermore,
oxidative stress is known to induce the expression of this
gene [195]. In general, PGC-1α improves mitochondrial
dysfunction, the major phenotype of aging and age-related
diseases, in a tissue-dependent fashion [196] and during CR
promotes mitochondrial biogenesis [197], thereby lowering
ROS production [198]. PGC-1α is also directly activated by
phosphorylation by AMPK that is the master nutrient sensor
in the cell [199]. The same kinase is able to phosphorylate
FoxO factors too [200].
Recently another protein, named Bmi1, has demon-
strated to increase the expression of a collection of gene
products involved in mitochondrial function and ROS
production in aging. Cells defective in Bmi1 have signiﬁcant
mitochondrial dysfunction with a sustained increase in
ROS that is suﬃcient to cause a marked increase in the
intracellular levels of reactive oxygen species and subsequent
engagement of the DNA damage response pathway. Also
mice Bmi1 −/− present numerous abnormalities including
a severe defect in stem cell self-renewal, alterations in
thymocyte maturation, and a shortened lifespan [201].
Aging is characterized also by the decline of the
autophagic pathway [202]. As described in the previous sec-
tion, autophagy is required in order to remove compromised
mitochondria suﬀering from oxidative stress. Moreover,
autophagy modulation in diﬀerent model organisms has
yielded very promising results suggesting that the mainte-
nance of a proper autophagic activity contributes to extend
longevity [203]. During aging, the number of mitochondria
suﬀering from oxidative stress may increase, while their
cleanup by the autophagic system may become limiting,
leadingtotheaccumulationofdamagedmitochondria[204].
It is important to point out that a greater pool of functional
mitochondria could ameliorate tissue damage by opposing
cells against the gradual energetic decline occurring in cells
as mitochondria become damaged during aging [171].
In this respect, the eﬃcient and selective removal of
damaged mitochondria by autophagy is a crucial element in
the maintenance of cellular health since the accumulation
of ROS from dysfunctional mitochondria and eventual cell
death via apoptosis is avoided [204]. At the level of the
organism, apoptosis will be the ultimate resort to remove
seriously damaged cells. This will particularly aﬀect the
lifespan of nondividing cells, like neurons, thereby, aﬀecting
the lifespan of the whole organism. Indeed, the degenerative
processes that arise in old organisms are partly caused by
increased cell death of nondividing cells [205]. In any
case, the accumulation of damaged mitochondria and their
impaired removal is a hallmark of aging and will contribute
to decreased cell viability. Interestingly, autophagy is regu-
lated by the same signaling pathways that determine lifespan,
acting as one of the downstream eﬀectors of these signaling
cascades. Autophagy is essential for the eﬀects of the IGF-
1/insulin pathway on longevity. The insulin/IGF-1 pathway
regulates autophagy through TOR and FoxO, with opposite
eﬀects; TOR was shown to inhibit autophagy [206, 207],
while FoxO induces autophagy [208, 209]. Moreover, SIRT1
seems to be, at least in part, responsible for the direct
induction of autophagy [210], as it forms complexes with
several autophagy-related genes (ATG) proteins, causing
their deacetylation and activation [211]. Autophagy is sug-
gested to be crucial also for the onset of age-related diseases
since knockout animals for ATG5 and ATG7 in the nervous
system show the accumulation of abnormal proteins and
massive neuronal loss leading to neurodegeneration with
decreased lifespan [212, 213]. Altogether, these data suggest
the presence in the cell of a redundant control of autophagy
that allows to ﬁnely tune this process under a wide array of
physiological and pathological conditions.
7. Concluding Remarks
Mitochondria and ROS signalling tightly control cellular
homeostasis by regulating fundamental cell-death and cell-
survival processes like apoptosis and autophagy. Therefore,
ROS production may be considered a “balance of power,”
directing the cell towards life or death. It is clear that many
proteinsthatmediateapoptosisandautophagydirectlyaﬀect
ROS signalling, through translocation to the mitochondrial
compartment and/or modulation of pro/antioxidant pro-
teins. Although correlation between mitochondrial ROS and
aging has been the subject of debate for over forty years,
recent discoveries about the role of autophagy in cleaning up
damaged mitochondria, prolonging lifespan, underline the
importance of studying ROS dynamics and show that they
continue to be extremely fashionable research targets.
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